register

News & Trends - Pharmaceuticals

New Parliamentary group to advance pain management in light of recent PBS changes

Health Industry Hub | July 29, 2020 |

Pharma News: Painaustralia announced the establishment of the new Parliamentary Friends of Pain Management group of the Federal Parliament.

Painaustralia Chairman Professor Ian Chubb welcomed the new group “This is a clear indication that federal parliamentarians understand the significant impact that chronic pain has on our community.  It is wonderful to see the strong bi-partisan support and I would like to thank each and every one of the members of this group for their enthusiastic response to the invitation. This group and its members will promote more discussion in the halls of parliament about practical solutions to addressing the needs of the 3.37 million Australians living with pain.  I am optimistic we will see great progress on this front.”

The Parliamentary Friends of Pain Management Group will be co-chaired by The Hon David Smith MP and Senator Wendy Askew.

Painaustralia’s CEO, Carol Bennett said “With the impact of the global COVID-19 pandemic together with recent changes to availability of pain medications, people living with chronic pain are doing it tough.  It is important that some of our community’s most disadvantaged people are placed at the centre of national health discussion and we are in a position as a nation to provide national leadership to this major health challenge.”.

New and emerging evidence continues to highlight the significant potential for an increase in chronic pain after the COVID-19 pandemic. “Nearly 70% of people living with chronic pain are of working age and almost 50% also live with mental health conditions like anxiety and depression. This condition exacts an enormous toll,” Ms Bennett said.

“We know that if our policy framework to treat pain doesn’t change, then the annual cost of pain in Australia will rise from $140 billion to over $215 billion by 2050. Importantly, this modelling by Deloitte Access Economics was done before we factored in the additional impost of the COVID-19 pandemic,” Ms Bennett said.

Painaustralia was funded by the Australian Government to develop the National Strategic Action Plan for Pain Management which was launched in 2019.  The Plan outlines the key actions that Australia should take to tackle chronic pain.   It is currently before Australia’s health ministers for approval.

“I am confident that the political leadership of this group will make a difference in the lives of millions of Australians living with chronic pain, their families and carers and the communities they contribute to. Painaustralia thanks our co-chairs and each of the parliamentarians who have signed up to support a strategic national approach to managing chronic pain,” Ms Bennett said.


News & Trends - Pharmaceuticals

Is the government is gearing up to release the long-awaited response to The New Frontier report?

Government’s long-awaited response to The New Frontier report unveiled after two-year wait

Health Industry Hub | December 1, 2023 |

Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]

More


News & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the 'unsung heroes'

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’

Health Industry Hub | December 1, 2023 |

Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]

More


News & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn's disease in seven years

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years

Health Industry Hub | December 1, 2023 |

Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]

More


ESG

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding

Health Industry Hub | November 30, 2023 |

ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]

More


This content is copyright protected. Please subscribe to gain access.